Location: Miami, FL
CIK: 0001937964 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $499M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLC | 95,376 | $18.81M | 3.8% | $190.39 | 0.0% | ORD | G0593M107 |
| MRNA | MODERNA INC | 200,000 | $10.16M | 2.0% | — | — | CALL | 60770K107 |
| ALMS | ALUMIS INC | 325,046 | $7.161M | 1.4% | $24.33 | 0.0% | COM | 022307102 |
| MRK | MERCK & CO INC | 46,700 | $5.618M | 1.1% | $114.28 | 0.0% | COM | 58933Y105 |
| TERN | TERNS PHARMACEUTICALS INC | 104,800 | $5.525M | 1.1% | $37.46 | 0.0% | COM | 880881107 |
| JNJ | JOHNSON & JOHNSON | 22,600 | $5.524M | 1.1% | $227.87 | 0.0% | COM | 478160104 |
| BIIB | BIOGEN INC | 18,437 | $3.38M | 0.7% | $183.25 | 0.0% | COM | 09062X103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 65,500 | $2.063M | 0.4% | $28.18 | 0.0% | COM | 28036F105 |
| CYTK | CYTOKINETICS INC | 16,300 | $1.074M | 0.2% | $64.44 | 0.0% | COM NEW | 23282W605 |
| ELVN | ENLIVEN THERAPEUTICS INC | 20,900 | $819K | 0.2% | $25.60 | 0.0% | COM | 29337E102 |
| APGE | APOGEE THERAPEUTICS INC | 5,886 | $495K | 0.1% | $72.23 | 0.0% | COM | 03770N101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 124,990 (+20.0%) | $12.16M (+46.5%) | 2.4% | $57.26 | +79.9% | COM | 76155X100 |
| XENE | XENON PHARMACEUTICALS INC | 65,000 (+62.5%) | $3.78M (+110.8%) | 0.8% | $44.45 | -5.6% | COM | 98420N105 |
| BLTE | BELITE BIO INC | 24,989 (+38.9%) | $3.984M (+38.5%) | 0.8% | $159.81 | — | SPONSORED ADS | 07782B104 |
| BTSG | BRIGHTSPRING HEALTH SVCS INC | 53,800 (+29.3%) | $2.292M (+47.1%) | 0.5% | $26.91 | +46.5% | COM | 10950A106 |
| CELC | CELCUITY INC | 15,576 (+20.7%) | $1.778M (+38.2%) | 0.4% | $86.55 | +24.2% | COM | 15102K100 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 38,407 (+15.0%) | $2.803M (+7.5%) | 0.6% | $69.07 | +21.6% | COM NEW | 10919W405 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UGL | PROSHARES TR II | 442,119 | $24.55M | 4.9% | $46.06 | — | — | 74347W601 |
| QURE | UNIQURE NV | 1,023,539 | $24.49M | 4.9% | $25.44 | -7.4% | — | N90064101 |
| AZN | ASTRAZENECA PLC | 190,752 | $17.54M | 3.5% | $69.76 | — | — | 046353108 |
| — | CIDARA THERAPEUTICS INC | 70,824 | $15.64M | 3.1% | $220.89 | — | — | 171757206 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 17,400 | $6.919M | 1.4% | $280.16 | +26.1% | — | 02043Q107 |
| VTYX | VENTYX BIOSCIENCES INC | 695,982 | $6.285M | 1.3% | $7.47 | +80.9% | — | 92332V107 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 59,200 | $6.196M | 1.2% | $85.31 | +7.1% | — | 697947109 |
| UGL | PROSHARES TR II | 100,000 | $5.552M | 1.1% | $46.06 | — | PUT | 74347W601 |
| RNAM | AVIDITY BIOSCIENCES INC | 60,100 | $4.335M | 0.9% | $37.09 | +95.9% | — | 05370A108 |
| SLNO | SOLENO THERAPEUTICS INC | 50,000 | $2.315M | 0.5% | $55.51 | -25.0% | CALL | 834203309 |
| UPB | UPSTREAM BIO INC | 68,653 | $1.864M | 0.4% | $24.89 | -4.9% | — | 91678A107 |
| OCUL | OCULAR THERAPEUTIX INC | 141,061 | $1.712M | 0.3% | $11.96 | -17.8% | — | 67576A100 |
| ABVX | ABIVAX SA | 9,900 | $1.335M | 0.3% | $116.11 | — | CALL | 00370M103 |
| OCUL | OCULAR THERAPEUTIX INC | 85,200 | $1.034M | 0.2% | $11.96 | -17.8% | CALL | 67576A100 |
| ANRO | ALTO NEUROSCIENCE INC | 29,192 | $520K | 0.1% | $12.59 | +33.1% | — | 02157Q109 |
| LYRA | LYRA THERAPEUTICS INC | 8,756 | $26,968 | 0.0% | $4.98 | -59.3% | — | 55234L204 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 29,739 (-54.0%) | $21.72M (-60.1%) | 4.3% | $527.57 | — | SPONSORED ADR | 04016X101 |
| INSM | INSMED INC | 279,700 (-33.4%) | $45.74M (-37.4%) | 9.2% | $72.29 | +120.0% | PUT | 457669307 |
| SLNO | SOLENO THERAPEUTICS INC | 68,490 (-87.2%) | $2.293M (-90.7%) | 0.5% | $55.51 | -25.0% | COM | 834203309 |
| VKTX | VIKING THERAPEUTICS INC | 180,731 (-74.9%) | $5.881M (-76.8%) | 1.2% | $34.07 | -8.0% | COM | 92686J106 |
| LLY | ELI LILLY & CO | 38,220 (-24.3%) | $35.15M (-35.2%) | 7.0% | $882.32 | +18.7% | COM | 532457108 |
| INSM | INSMED INC | 628,712 (-7.8%) | $103M (-13.4%) | 20.6% | $72.29 | +120.0% | COM PAR $.01 | 457669307 |
| DNTH | DIANTHUS THERAPEUTICS INC | 162,990 (-20.5%) | $13.68M (+61.8%) | 2.7% | $31.76 | +49.8% | COM | 252828108 |
| PROK | PROKIDNEY CORP | 1,806,939 (-1.7%) | $3.234M (-21.5%) | 0.6% | $2.63 | -18.8% | SHS CL A | 74291D104 |
| AVTX | AVALO THERAPEUTICS INC | 28,970 (-30.3%) | $433K (-42.7%) | 0.1% | $16.88 | -8.2% | COM NEW | 05338F306 |
| NUVL | NUVALENT INC | 4,900 (-39.5%) | $502K (-38.4%) | 0.1% | $98.60 | +5.1% | COM | 670703107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 600,747 | $66.89M | 13.4% | $116.11 | — | SPONSORED ADS | 00370M103 |
| EYPT | EYEPOINT INC | 767,098 | $9.888M | 2.0% | $11.20 | +35.9% | COM NEW | 30233G209 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 503,936 | $16.13M | 3.2% | $31.28 | +7.9% | ORDINARY SHARES | N62509109 |
| MLYS | MINERALYS THERAPEUTICS INC | 137,800 | $3.733M | 0.7% | $30.39 | +3.2% | COM | 603170101 |
| PALI | PALISADE BIO INC | 1,992,367 | $3.487M | 0.7% | $1.92 | -7.2% | COM | 696389402 |
| TRVI | TREVI THERAPEUTICS INC | 2,013,602 | $24.02M | 4.8% | $6.66 | +64.3% | COM | 89532M101 |
| PEPG | PEPGEN INC | 205,324 | $363K | 0.1% | $5.19 | +12.3% | COM | 713317105 |
| DGX | QUEST DIAGNOSTICS INC | 40,817 | $7.999M | 1.6% | $165.04 | +15.5% | COM | 74834L100 |
| ROIV | ROIVANT SCIENCES LTD | 129,800 | $3.595M | 0.7% | $19.73 | +22.5% | SHS | G76279101 |
| TVTX | TRAVERE THERAPEUTICS INC | 70,700 | $2.1M | 0.4% | $27.18 | +14.2% | COM | 89422G107 |
| IONS | IONIS PHARMACEUTICALS INC | 144,376 | $10.84M | 2.2% | $64.26 | +27.3% | COM | 462222100 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 5,000 | $2.965M | 0.6% | $342.70 | +40.2% | COM | 91307C102 |
| SRRK | SCHOLAR ROCK HLDG CORP | 96,285 | $4.733M | 0.9% | $38.47 | +18.2% | COM | 80706P103 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 22,931 | $2.417M | 0.5% | $36.55 | +127.9% | COM | 74366E102 |
| ASND | ASCENDIS PHARMA A/S | 17,740 | $4.058M | 0.8% | $176.21 | — | SPONSORED ADR | 04351P101 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 29,200 | $1.406M | 0.3% | $25.46 | +69.6% | ORD SHS CL A | G52694109 |
| KOD | KODIAK SCIENCES INC | 17,019 | $649K | 0.1% | $20.48 | +24.1% | COM | 50015M109 |
| TENX | TENAX THERAPEUTICS INC | 42,080 | $673K | 0.1% | $8.70 | +55.2% | COM NEW | 88032L605 |
| ABBV | ABBVIE INC | 14,500 | $3.154M | 0.6% | $182.67 | +21.8% | COM | 00287Y109 |
| RAPP | RAPPORT THERAPEUTICS INC | 138,508 | $4.334M | 0.9% | $23.09 | +20.5% | COM | 75383L102 |
| SION | SIONNA THERAPEUTICS INC | 119,741 | $4.8M | 1.0% | $37.92 | +3.5% | COM | 829401108 |
| PRAX | PRAXIS PRECISION MEDICINES I | 2,500 | $805K | 0.2% | $186.22 | +67.4% | COM NEW | 74006W207 |
| BBIO | BRIDGEBIO PHARMA INC | 20,400 | $1.515M | 0.3% | $48.77 | +52.7% | COM | 10806X102 |